» Articles » PMID: 28481908

Effect of Intravenous Immunoglobulin on the Function of Treg Cells Derived from Immunosuppressed Mice with Pseudomonas Aeruginosa Pneumonia

Overview
Journal PLoS One
Date 2017 May 9
PMID 28481908
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: The present study aimed to investigate the effect of intravenous immunoglobulin (IVIG) on regulatory T (Treg) cells derived from immunosuppressed mice with Pseudomonas aeruginosa (PA) pneumonia.

Methods: A total of 108 BALB/c mice were randomly divided into the following groups: control group (Control), immunosuppressed group (IS), PA pneumonia group (PA), PA pneumonia in immunosuppressed group (IS + PA), PA pneumonia with IVIG treatment in immunocompetent group (PA + IVIG) and PA pneumonia with IVIG treatment in immunosuppressed group (IS + PA + IVIG). Each group comprised 18 mice. The combined PA pneumonia in immunosuppressed model and the treatment models were established. The mice in each group were sacrificed at 4, 8, and 24 h time points. The general condition and pathological changes in the lung tissues of the mice were monitored. Reverse transcription-polymerase chain reaction was used to detect the forkhead box P3 (FOXP3) mRNA relative expression level in the lung tissues. The enzyme-linked immunosorbent assay was used to detect the serum concentration of active transforming growth factor beta (TGF-β).

Results: No inflammatory response were exhibited in the lung tissues of the mice in Control group and IS group, while varying degrees of acute lung injury were revealed in the mice in PA group, IS + PA group, PA + IVIG group and IS + PA + IVIG group. Lung tissue injury was most apparent at the 8 h time point, and it indicated the greatest effect in IS + PA group. Whereas tissue damages were alleviated in PA + IVIG group and IS + PA + IVIG group compared with IS + PA group. In addition, tissue damage lessened in PA + IVIG group compared with PA group and IS + PA + IVIG group. FOXP3 mRNA expression levels in the lung tissues and the serum concentration of TGF-β were lower in IS group, PA group, IS + PA group and IS + PA + IVIG group at the 4, 8 and 24 h time points, respectively compared with Control group. FOXP3 mRNA expression levels decreased in PA + IVIG group at the 4h time point and TGF-β serum concentrations decreased at the 4 and 8h time points compared with Control group, and subsequently increased.

Conclusions: In the immunosuppred model with PA pneumonia, the immune system was greatly compromised. IVIG partially restored the immunosuppressed functions of Treg cells, suppressed the overactivated immune system and ameliorated the development of the disease.

Citing Articles

Regulatory T cells in lung disease and transplantation.

Lao P, Chen J, Tang L, Zhang J, Chen Y, Fang Y Biosci Rep. 2023; 43(10).

PMID: 37795866 PMC: 10611924. DOI: 10.1042/BSR20231331.


Autoinducer-2 promotes PAO1 acute lung infection the IL-17A pathway.

Li H, Li X, Ai Q, Tan L Front Microbiol. 2022; 13:948646.

PMID: 36033859 PMC: 9404534. DOI: 10.3389/fmicb.2022.948646.


Treatment with IgM-enriched intravenous immunoglobulins enhances clearance of stroke-associated bacterial lung infection.

McCulloch L, Harris A, Malbon A, Daniels M, Younas M, Grainger J Immunology. 2022; 167(4):558-575.

PMID: 35881080 PMC: 11495265. DOI: 10.1111/imm.13553.


Kawasaki Disease: The Role of Immune Complexes Revisited.

Menikou S, Langford P, Levin M Front Immunol. 2019; 10:1156.

PMID: 31263461 PMC: 6584825. DOI: 10.3389/fimmu.2019.01156.


Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.

Curran C, Bolig T, Torabi-Parizi P Am J Respir Crit Care Med. 2017; 197(6):708-727.

PMID: 29087211 PMC: 5855068. DOI: 10.1164/rccm.201705-1043SO.

References
1.
Katz-Agranov N, Khattri S, Zandman-Goddard G . The role of intravenous immunoglobulins in the treatment of rheumatoid arthritis. Autoimmun Rev. 2015; 14(8):651-8. DOI: 10.1016/j.autrev.2015.04.003. View

2.
Hill N . Noninvasive ventilation for immunocompromised patients. N Engl J Med. 2001; 344(7):522-4. DOI: 10.1056/NEJM200102153440711. View

3.
Basta M, Branch D . 7th International Immunoglobulin Conference: Mechanisms of action. Clin Exp Immunol. 2014; 178 Suppl 1:111. PMC: 4285512. DOI: 10.1111/cei.12532. View

4.
Schwab I, Nimmerjahn F . Intravenous immunoglobulin therapy: how does IgG modulate the immune system?. Nat Rev Immunol. 2013; 13(3):176-89. DOI: 10.1038/nri3401. View

5.
Eibl M . History of immunoglobulin replacement. Immunol Allergy Clin North Am. 2008; 28(4):737-64, viii. DOI: 10.1016/j.iac.2008.06.004. View